Remedium Lifecare Limited (BOM:539561)

Market Cap	624.96M
Revenue (ttm)	4.41B
Net Income (ttm)	51.42M
Shares Out	403.20M
EPS (ttm)	0.09
PE Ratio	16.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,305,700
Average Volume	9,904,035
Open	1.560
Previous Close	1.560
Day's Range	1.490 - 1.600
52-Week Range	0.800 - 7.040
Beta	1.13
RSI	62.93
Earnings Date	Nov 12, 2025

About Remedium Lifecare

Remedium Lifecare Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium met...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1988
• Employees: 7
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539561

Financial Performance

In 2024, Remedium Lifecare's revenue was 4.05 billion, a decrease of -89.97% compared to the previous year's 40.42 billion. Earnings were 21.29 million, a decrease of -93.49%.